IL17A and metabolic dysfunction-associated steatotic liver disease: Focusing on OLFM4, as stated above, its relative mRNA expression in the jejunum did not present significant differences between NAFLD groups, but we did observe positive associations with IL-8, IL-10 and IL-17 levels and jejunal TLR9 expression.